Partnering & Licensing

partnering2

Partnering With Us

TRIANNI partners with other companies interested developing therapeutic monoclonal antibodies by utilizing our proprietary platform – The Trianni Mouse. Licensing is available directly or through CROs for use in their antibody discovery solutions. Contact us for more information.

Discovery Partners

TRIANNI’s Discovery Partners include several medium-large pharma partners. Below is representative of those that are publicly announced.

Takeda-01
achaogen-01
merck-logo-01
innovent-01
sanofi-01
austrianni-01
FredHutch
gigagen-01
Immunomic-01
OPT-01

In addition to the above, Trianni, Inc holds agreements with Janssen Biotech, Inc. and  Magenta Therapeutics

Academic Agreements

Trianni, Inc holds licensing agreements with Massachusetts General Hospital,  Stanford University  and the  University of Alabama, Birmingham.

Preferred Contract Research Provider Partners

AntibodySolutions-01
Chempartner